The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

David H. Ilson

Gastrointestinal Oncology Service

Department of Medicine

Memorial Sloan-Kettering Cancer Center

New York

New York

[email]@mskcc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. 2003 - 2012
  • Memorial Sloan-Kettering Cancer Center, New York, USA. 1998 - 2007

References

  1. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Ilson, D.H., Minsky, B.D., Ku, G.Y., Rusch, V., Rizk, N., Shah, M., Kelsen, D.P., Capanu, M., Tang, L., Campbell, J., Bains, M. Cancer (2012) [Pubmed]
  2. A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus. Ilson, D.H., Kelsen, D., Shah, M., Schwartz, G., Levine, D.A., Boyd, J., Capanu, M., Miron, B., Klimstra, D. Cancer (2011) [Pubmed]
  3. Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer. Ilson, D.H., Wadleigh, R.G., Leichman, L.P., Kelsen, D.P. Ann. Oncol. (2007) [Pubmed]
  4. Cancer of the gastroesophageal junction: Current therapy options. Ilson, D.H. Curr. Treat. Options. Oncol (2006) [Pubmed]
  5. Cancer of the gastroesophageal junction: combined modality therapy. Ilson, D.H. Surg. Oncol. Clin. N. Am. (2006) [Pubmed]
  6. New developments in the treatment of esophageal cancer. Ilson, D.H. Clin. Adv. Hematol. Oncol (2004) [Pubmed]
  7. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. Ilson, D.H., Bains, M., Kelsen, D.P., O'Reilly, E., Karpeh, M., Coit, D., Rusch, V., Gonen, M., Wilson, K., Minsky, B.D. J. Clin. Oncol. (2003) [Pubmed]
  8. Irinotecan in esophageal cancer. Ilson, D.H., Minsky, B. Oncology (Williston Park, N.Y.) (2003) [Pubmed]
  9. Oesophageal cancer: new developments in systemic therapy. Ilson, D.H. Cancer Treat. Rev. (2003) [Pubmed]
  10. New developments in the treatment of esophageal cancer. Ilson, D.H. Curr. Oncol. Rep (2002) [Pubmed]
  11. Adjuvant therapy for noncolorectal cancers. Ilson, D.H. Curr. Opin. Oncol (2001) [Pubmed]
  12. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. Ilson, D.H., Saltz, L., Enzinger, P., Huang, Y., Kornblith, A., Gollub, M., O'Reilly, E., Schwartz, G., DeGroff, J., Gonzalez, G., Kelsen, D.P. J. Clin. Oncol. (1999) [Pubmed]
  13. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. Ilson, D.H., Ajani, J., Bhalla, K., Forastiere, A., Huang, Y., Patel, P., Martin, L., Donegan, J., Pazdur, R., Reed, C., Kelsen, D.P. J. Clin. Oncol. (1998) [Pubmed]
 
WikiGenes - Universities